Directed new share issue in Axis Biochemicals ASA (NO) — NOK 31 million

Carnegie acted as sole manager to Axis Biochemicals ASA in the company’s directed new issue. Axis Biochemicals ASA is listed on the Oslo Stock Exchange and develops technologies for medical diagnostics.November, 1998.